A. de Gramont

Type de document

Articles (4) Recensions (1)

Co-auteur

A. Tijeras-Raballand

E. Raymond

S. Faivre

R. Cohen

B. Chibaudel

J. Zalcberg

T. Yoshino

A.D. Wagner

M.M. Voss

C. Tournigand

N.C. Tebbutt

K. Slimane

Q. Shi

E. Shacham-Shmueli

M. Serova

S. Sebbagh

L.B. Saltz

J. Paget

C.L. Olswold

D. Notelet

C. Neuzillet

O. Margalit

H.J. Lenz

P. Laurent-Puig

F.F. Kabbinavar

H. Hurwitz

W.S. Harmsen

A. Hadengue

A. Grothey

D.A. Goldstein

C. Dos Santos

M.H. de Larauze

B. Boursi

F. Bonnetain

M. Benetkiewicz

T. André

R.A. Adams

Date

Source

Serveur académique Lausannois (4)

Mot-clé

Treatment (4) thérapie (3) effet (3) Therapeutics (3) Human beings (3) recherche (2) modèle (2) maladie (2) procès (2) survie (2) Development (2) Chemotherapy (2) Control (2) Trials (2) Survival (2) Strategy (2) Research (2) Patients (2) Management (2) Impact (2) Growth (2) Example (2) Chemotherapy (2) Cancer (2) Agent (Philosophy) (2) Older people (2) Bevacizumab (2) Research (2) Use (2) Patients (2)

Documents écrit par A. de Gramont (4) | parle de A. de Gramont (14)

Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3,369 patients in the ARCAD database.

O. Margalit et al.

Effects of preset sequential administrations of sunitinib and everolimus on tumour differentiation in Caki-1 renal cell carcinoma.

C. Dos Santos et al. (2015)

Targeting cancer cell metabolism in pancreatic adenocarcinoma.

R. Cohen et al. (2015)

STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancer.

B. Chibaudel et al. (2015)